Neuronetics, Inc. (STIM) Profit Breakdown
- 2026-06-30: Products $11.37M; Services $9.86M.
- 2025-06-30: Products $10.77M; Services $6.99M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2016-12-31 to 2026-06-30
- Data captured
Profit by product
Gross margin: each quarter (3 month)
| Quarter end | Products | Services |
|---|---|---|
| 2026-06-30 | $11.37M derived | $9.86M derived |
| 2025-06-30 | $10.77M derived | $6.99M derived |
Gross profit: each quarter (3 month)
| Quarter end | NeuroStar | Greenbrook |
|---|---|---|
| 2026-06-30 | $11.37M | $9.86M |
| 2025-06-30 | $10.77M | $6.99M |
Operating income: each quarter (3 month)
| Quarter end | NeuroStar | Greenbrook |
|---|---|---|
| 2026-06-30 | $3.13M | $2.19M |
| 2025-06-30 | $146.00K | -$405.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |